LICENSE AGREEMENTLicense Agreement • March 8th, 2017 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
This License Agreement (this "Agreement") is made effective as of March 8, 2017 (the "Effective Date") by and between Apricus Biosciences, Inc., a Nevada corporation ("Apricus"), and Ferring International Center S.A., a Swiss corporation ("Ferring"). Apricus and Ferring are each hereinafter referred to individually as a "Party” and together as the “Parties." Capitalized terms that are used and not defined in this Agreement shall have their respective meanings set forth in the Purchase Agreement (as defined below).
ASSET PURCHASE AGREEMENT By and between FERRING INTERNATIONAL CENTER S.A. And APRICUS BIOSCIENCES, INC., NEXMED (U.S.A.), INC., NEXMED HOLDINGS, INC., AND NEXMED INTERNATIONAL LIMITEDAsset Purchase Agreement • March 8th, 2017 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and executed as of March 8, 2017 (the “Execution Date”), by and between Apricus Biosciences, Inc., a Nevada corporation (“Seller”), NexMed (U.S.A.), Inc., a Delaware corporation (“NexMed U.S.A.”), NexMed Holdings, Inc., a Delaware corporation (“NexMed Holdings”), NexMed International Limited, a British Virgin Islands corporation (“NexMed International,” and together with Seller, NexMed U.S.A. and NexMed Holdings, the “Seller Parties”), on the one hand, and Ferring International Center S.A., a Swiss corporation (“Purchaser”), on the other hand. The Seller Parties and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
TRANSITION SERVICES AGREEMENTTransition Services Agreement • March 8th, 2017 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
TRANSITION SERVICES AGREEMENT (“Agreement”) dated as of March 8, 2017 is made by and between Apricus Biosciences, Inc., a Nevada corporation (“Seller”), and Ferring International Center S.A., a Swiss corporation (“Buyer”). Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Asset Purchase Agreement, dated as of March 8, 2017, (the “Purchase Agreement”) between Buyer, Seller, NexMed (U.S.A.), Inc., a Delaware corporation (“NexMed U.S.A.”), NexMed Holdings, Inc., a Delaware corporation (“NexMed Holdings”), NexMed International Limited, a British Virgin Islands corporation (“NexMed International” and together with the Seller, NexMed U.S.A. and NexMed Holdings, the “Seller Parties”). Capitalized terms that are used and not defined in this Agreement shall have their respective meanings set forth in the Purchase Agreement.
